Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

University of Florida researchers said a new study could lead to a universal cancer shot, while digital health earnings ...

A new study in mice shows that tirzepatide—the active ingredient in the popular drugs Mounjaro and Zepbound—not only helps shed pounds but may also slow or reduce the growth of breast cancer tumors ...